Hanke M G Wiegers
Overview
Explore the profile of Hanke M G Wiegers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamulyak E, Wiegers H, Hutten B, de Lange M, Timmermans A, Westerweel P, et al.
Res Pract Thromb Haemost
. 2024 Jul;
8(4):102448.
PMID: 38953049
No abstract available.
2.
Wiegers H, Farkas D, Horvath-Puho E, Middeldorp S, van Es N, Sorensen H
Lancet Haematol
. 2023 Mar;
10(5):e359-e366.
PMID: 36972715
Background: The incidence of superficial vein thrombosis (SVT) of the legs and the subsequent risk of venous thromboembolism during pregnancy and the post-partum period is unknown. To better understand the...
3.
Wiegers H, Schaafsma M, Guman N, Zelisse H, Mulder F, Middeldorp S, et al.
J Thromb Haemost
. 2023 Jan;
21(2):294-302.
PMID: 36700503
Background: Venous thromboembolism (VTE) is a frequent complication in patients with ovarian cancer after major surgery. Based on limited data, international guidelines recommend extended thromboprophylaxis for up to 28 days....
4.
Bistervels I, Wiegers H, Ainle F, Bleker S, Chauleur C, Donnelly J, et al.
J Thromb Haemost
. 2023 Jan;
21(1):57-67.
PMID: 36695396
Background: Peripartum management of women using low-molecular-weight heparin (LMWH) varies widely. Minimum time intervals are required between LMWH injection and neuraxial procedure, and they differ by dose. Objectives: The objective...
5.
Wiegers H, Knijp J, van Es N, Coppens M, Klok F, Middeldorp S, et al.
J Thromb Haemost
. 2023 Jan;
21(1):175-178.
PMID: 36695380
No abstract available.
6.
Bistervels I, Buchmuller A, Wiegers H, Ainle F, Tardy B, Donnelly J, et al.
Lancet
. 2022 Nov;
400(10365):1777-1787.
PMID: 36354038
Background: Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism. The optimal...
7.
Wiegers H, Knijp J, van Es N, Coppens M, Moll S, Klok F, et al.
J Thromb Haemost
. 2022 Feb;
20(5):1158-1165.
PMID: 35108438
Background: The risk of recurrence after a venous thromboembolism (VTE) related to estrogen-containing contraceptives is a key driver to guide anticoagulant treatment decisions. Objective: To estimate the incidence rate of...
8.
Nijsten K, van der Minnen L, Wiegers H, Koot M, Middeldorp S, Roseboom T, et al.
Br J Nutr
. 2021 Jul;
128(1):30-42.
PMID: 34325760
Hyperemesis gravidarum (HG), severe nausea and vomiting in pregnancy, can lead to vitamin deficiencies. Little is known about HG-related vitamin K deficiency. We aimed to summarise available evidence on the...
9.
Wiegers H, van Es J, Pap A, Lensing A, Middeldorp S, Scheres L
J Thromb Haemost
. 2021 Apr;
19(7):1759-1763.
PMID: 33829647
Background: It is unknown whether differences in clot structure and resolution contribute to the reported risk differences of recurrent venous thromboembolism (VTE) between men and women. Patients/methods: We used data...
10.
Hamulyak E, Wiegers H, Scheres L, Hutten B, de Lange M, Timmermans A, et al.
Res Pract Thromb Haemost
. 2021 Feb;
5(1):223-230.
PMID: 33537547
Background: In premenopausal women, treatment with direct oral factor Xa inhibitors is associated with an increased risk of heavy menstrual bleeding (HMB) compared with vitamin K antagonists (VKA). Treatment with...